# Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological Analyses

> **NCT07731555** · NA · RECRUITING · sponsor: **Patrick Morris** · enrollment: 100 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DIAGNOSTIC_TEST:** Multimodal Blood Brain Barrier Assessment

## Key facts

- **NCT ID:** NCT07731555
- **Lead sponsor:** Patrick Morris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731555, "Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological Analyses". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07731555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
